Nearly 1 Crore Calls Later, India’s Tobacco Quitline Has Helped Over 2.3 Lakh People Quit

IMT News Desk
IMT News Desk
· 3 min read
India’s National Tobacco Quitline has handled 1 crore calls and helped over 2.3 lakh people quit, proving how simple counselling can save lives.

For years, India’s tobacco control efforts focused largely on regulations, warning labels and restrictions. Yet for millions already addicted to tobacco, quitting remained a deeply personal battle with limited access to professional support.

Since its launch in 2016, the National Tobacco Quitline Services (NTQLS) has received nearly 1 crore calls, registered over 6.75 lakh tobacco users, conducted more than 37 lakh counselling sessions, and helped 2,32,870 Indians successfully quit tobacco.

Reflecting on the importance of awareness-led action, Shri Manoj Tiwari, Member of Parliament, North East Delhi, says, “India’s fight against tobacco cannot succeed through laws and regulations alone. Tobacco addiction affects not just individuals but entire families and communities. The National Tobacco Quitline Services has shown how accessible counselling and timely guidance can help people reclaim their health and future. Protecting young people from nicotine addiction is a collective national responsibility.”

The story behind the Quitline begins with a simple observation made years ago by Dr. Raj Kumar, Director of the Vallabhbhai Patel Chest Institute (VPCI) and Coordinator of NTQLS.

“India has one of the world’s largest populations of tobacco users and for years there was no free, structured support system available at a national scale,” says Dr. Raj Kumar. “The Quitline gave every Indian who wanted to quit access to trained professional guidance regardless of where they lived, what language they spoke, or their financial circumstances.”

Over the years, the initiative has expanded its footprint across every state and union territory. Uttar Pradesh alone has contributed more than two lakh registrations, while young adults aged 18–24 years account for the largest share of successful quitters, highlighting a growing willingness among younger Indians to break free from nicotine dependence.

Public health experts believe the achievement is especially noteworthy given India’s enormous tobacco burden.

India is home to an estimated 267 million tobacco users, while tobacco-related diseases claim more than 1.35 million lives every year. Despite this, cessation services remain significantly underutilised and under-resourced.

According to Dr. Digambar Behera, Padma Shri awardee and President of the National Academy of Medical Sciences (NAMS), the Quitline has become one of the country’s most scalable public health interventions.

“What Dr. Raj Kumar and his team have created is India’s only nationally accessible, professionally staffed and free cessation support infrastructure. Achieving a quit rate of more than 34 per cent among registered users compares favourably with some of the best international Quitline programmes.”

In an era when healthcare innovation is often associated with sophisticated technologies and expensive treatments, the success of the National Tobacco Quitline Services tells a different story.

For more than 2.3 lakh Indians, recovery did not begin in a hospital or clinic. It began with a phone call.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk